# Liraglutide Treatment to Patients With Severe Renal Insufficiency

> **NCT01394341** · PHASE4 · COMPLETED · sponsor: **Bo Feldt-Rasmussen** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- End-stage Renal Disease

## Interventions

- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT01394341
- **Lead sponsor:** Bo Feldt-Rasmussen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-10-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01394341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01394341, "Liraglutide Treatment to Patients With Severe Renal Insufficiency". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01394341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*